RPS29P28

Across TCGA pan-cancer cohorts, RPS29P28 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RPS29P28 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RPS29P28 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS29P28 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

OV, ESCA, and ACC are the cancer types where RPS29P28 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.008	0.760	<.001	126	view →
ESCA	DFS	Tertile	All	0.240	0.547	.002	72	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
BRCA	OS	Tertile	All	0.131	0.578	.029	24	view →
UCEC	OS	Tertile	All	0.806	0.929	.006	24	view →
GBM	OS	Tertile	All	0.142	0.415	.031	9	view →
SKCM	DFS	Tertile	All	1.000	0.614	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RPS29P28–OV (OS)

Open the OV breakdown →